Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Kölblinger

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 2, 2012
Non-invasive diagnosis of focal liver lesions: an individualized approachWolfgang Schima, Claus Kölblinger, Ahmed Ba-Ssalamah
European Radiology|October 6, 2006
Pancreatic adenocarcinomaWolfgang Schima, Ahmed Ba-Ssalamah, Claus Kölblinger, et al.
European Journal of Radiology|June 7, 2017
Early response evaluation using CT-perfusion one day after transarterial chemoembolization for HCC predicts treatment response and long-term disease controlDietmar Tamandl, Fredrik Waneck, Wolfgang Sieghart, et al.
Radiology|July 2, 2015
Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a PlaceboMatthias Pinter, Gregor Ulbrich, Wolfgang Sieghart, et al.
Radiology|March 23, 2012
Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenibMatthias Pinter, Florian Hucke, Ivo Graziadei, et al.
United European Gastroenterology Journal|July 19, 2019
Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinomaBernhard Scheiner, Gregor Ulbrich, Mattias Mandorfer, et al.
Wiener Klinische Wochenschrift|September 1, 2018
Austrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesionsDietmar Tamandl, Ahmed Ba-Ssalamah, Gernot Böhm, et al.
Wiener Klinische Wochenschrift|September 22, 2011
Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinomaMarkus Peck-Radosavljevic, Wolfgang Sieghart, Claus Kölblinger, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 2, 2012
Non-invasive diagnosis of focal liver lesions: an individualized approachWolfgang Schima, Claus Kölblinger, Ahmed Ba-Ssalamah
European Radiology|October 6, 2006
Pancreatic adenocarcinomaWolfgang Schima, Ahmed Ba-Ssalamah, Claus Kölblinger, et al.
European Journal of Radiology|June 7, 2017
Early response evaluation using CT-perfusion one day after transarterial chemoembolization for HCC predicts treatment response and long-term disease controlDietmar Tamandl, Fredrik Waneck, Wolfgang Sieghart, et al.
Radiology|July 2, 2015
Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a PlaceboMatthias Pinter, Gregor Ulbrich, Wolfgang Sieghart, et al.
Radiology|March 23, 2012
Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenibMatthias Pinter, Florian Hucke, Ivo Graziadei, et al.
United European Gastroenterology Journal|July 19, 2019
Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinomaBernhard Scheiner, Gregor Ulbrich, Mattias Mandorfer, et al.
Wiener Klinische Wochenschrift|September 1, 2018
Austrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesionsDietmar Tamandl, Ahmed Ba-Ssalamah, Gernot Böhm, et al.
Wiener Klinische Wochenschrift|September 22, 2011
Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinomaMarkus Peck-Radosavljevic, Wolfgang Sieghart, Claus Kölblinger, et al.
Pageof 1